Copper Run Marks 18 Years as Middle-Market M&A Enters a New Era of Complexity
B Record performance reflects growing demand for creative deal structuring and experienced advisory amid shifting market dynamics COLUMBUS, Ohio, April 23, 2026 /PRNewswire/ — Middle-market… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
CREATE Medicines Doses First Patient in Phase 1/2 Study of MT-304, a First-in-Class Multi-immune In Vivo CAR Therapy Targeting HER2-Positive Solid Tumors
B Validates platform’s ability to rapidly iterate across immune cell types Leverages novel NK and myeloid co-programming architecture to deliver coordinated immune activation Powered by… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
AP Strange SummaryBrief at 8:01 a.m. EDT
A A court orders Zambian government to return ex-president’s body to a funeral home in bizarre dispute JOHANNESBURG (AP) — A dispute over the remains… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
FLOWERS STILL REIGN SUPREME: 75% OF CONSUMERS CHOOSE BLOOMS FOR MOTHER’S DAY
B 1-800-Flowers Marks 50 Years of Celebrating Moms with New Insights on How America Is Gifting in 2026 JERICHO, N.Y., April 23, 2026 /PRNewswire/ — Flowers… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
¿Cuál es el secreto para disfrutar de la comodidad en todo el hogar? Un calentador de agua más inteligente y eficiente
B (BPT) – Imagine esto: es una noche fría y ha estado contando los minutos para disfrutar de una larga y relajante ducha con agua… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Mozart Therapeutics Announces Positive Interim Phase 1 Data in Adults with Stage 3 Type I Diabetes
P MTX-101 demonstrated decreases in self-reactive pathogenic T cells, improved β cell viability, and—at higher dose levels—numeric increase of C-peptide production SEATTLE and BRISBANE, Australia, April 23,… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
P Novel bispecific antibody with a dual mechanism of action targeting anemia of inflammation in chronic kidney disease, autoimmune disease, and cancer Experienced leadership and… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
ZeroEyes and High Tech High Collaboration Protects Students While Maintaining Open, Collaborative Learning Atmosphere
B Project-Based Charter School Network Demonstrates Commitment to Safety While Preserving Open, Relationship-Driven Culture PHILADELPHIA, April 23, 2026 /PRNewswire/ — ZeroEyes, creators of the leading AI-powered… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Cityblock Health Appoints New Chief Health Officer to Advance Technology-Enabled Clinical Care Model for Government Programs
B Former health plan and government executive, Dr. Alexander Billioux, joins executive team and brings deep expertise across clinical, policy, and population health initiatives BROOKLYN,… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Chestnut Carbon Doubles Footprint in Southeast U.S. to Nearly 70,000 Acres of Restored Forests
B Company Completes its Largest U.S. Planting Operation to Date NEW YORK, April 23, 2026 /PRNewswire/ — Chestnut Carbon (“Chestnut”), a leading U.S. developer of… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
